This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
The EURIPID Collaboration
EURIPID is a voluntary, non-profit collaboration of the European pricing and reimbursement authorities for the mutual sharing of information regarding pharmaceutical pricing policies and prices of medicinal products. Its main objective is to make pricing procedures and prices of pharmaceuticals more transparent in Europe. In order to do so, the EURIPID Collaboration set up and maintains a technical tool, the EURIPID database. The EURIPID database is a comprehensive, continuously maintained, easy-to-use online database of prices of reimbursed pharmaceuticals. The database is a resource tool for members of the EURIPID Collaboration and exclusively accessiblee for the national competent authorities of its participating countries and the services of the European Commission.
The EURIPID Collaboration consists of (1) founding members, (2) partners, (3) associated partners and (4) the European Commission (EC). Regarding its governance structure, the EURIPID Collaboration has a Board of Participants and an Executive Committee. The Board of Participants includes one delegate per country and a representative of the EC. The Executive Committee has six members: the delegates of the two founders, three delegates of the Board of Participants and one representative of the EC.
The EURIPID Collaboration is currently funded by an annual contribution fee of the participants and – for defined tasks (e.g. the public website) and deliverables – two grants of the European Commission awarded in 2019 and 2023.
1000000+
Price References of medical products
28
European countries participating
13
Years of Experience of project partners
60%
Funding by national Pricing and Reimbursement Authorities
History
The history of EURIPID started in 2008 with the launch of Common European Drug Database (CEDD) pilot project by the National Institute of Health Insurance Fund Management of Hungary.
In 2010, the first EURIPID project was launched by the two founding organisations – the National Institute of Health Insurance Fund Management of Hungary (Nemzeti Egészségbiztosítási Alapkezelő, NEAK) and the Austrian National Public Health Institute (Gesundheit Österreich GmbH, GÖG) supported by the Directorate General Enterprise and Industry (DG ENTR) of the European Commission. The project ended at the end of 2013 and at the same time the EURIPID Collaboration was established, solely funded by national pricing and reimbursement authorities.
In 2015 the Collaboration received funding from DG SANTE. In this project phase, the EURIPID Collaboration cooperated for the first time with Eurostat on calculating power purchasing parities (PPP) of pharmaceutical products and contacted the stakeholders of the European pharmaceutical sector. A follow-up of this cooperation is in progress since 2019.
Also in 2019, the Collaboration received another EC Grant to ensure communication, capacity building and dissemination of results. Important milestones of this grant were the establishment of the EURIPID Stakeholder Dialogue Platform on the EU Health Policy Platform, the launch of this public website and the start of a webinar series in 2022 (as the start was delayed by the COVID-19 pandemic).
In 2023 another Grant as part of the EU4Health Work programme was awarded to EURIPID. This time policy briefs (e.g., on excessive pricing) will be developed and capacity building will be continued. Since 2023 EURIPID is also regular member of the CAPR network of Member States.
